Navigation Links
Palatin Technologies to Present at 8th Annual BIO Investor Forum
Date:10/28/2009

CRANBURY, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) announced that it will be presenting at the 2009 BIO Investor Forum on Thursday, October 29, 2009 at 8:30 AM PDT. Hosted by the Biotechnology Industry Organization (BIO), the 8th Annual BIO Investor Forum will take place October 28-29 at the Palace Hotel in San Francisco, CA.

Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com.

SOURCE Palatin Technologies, Inc.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
2. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
3. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
4. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
5. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
6. BioStorage Technologies, Inc., Accelerates European Expansion with Opening of New German Facility
7. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
8. Greenway Medical Technologies Continues to Lead the Evolution of Healthcare Automation at National Health IT Week in Washington, D.C.
9. Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference
10. Noninvasive Medical Technologies Awarded ISO 13485 Quality Certification
11. ReBuilder Medical Technologies, Inc. Hiring! Increases Staff by 40%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin ... company that specializes in patented biopharmaceutical, modernized traditional ... ingredients (API) today announced that the Company achieved ... Good Manufacturing Practice (GMP) certificate of TPI,s Qionglai ... Administration,s (CFDA). The public notice period is a ...
(Date:12/24/2014)... and RALEIGH, N.C. , ... of Endo International plc (NASDAQ: ENDP ) ... BDSI ) announced today that they have submitted ... Film to the U.S. Food and Drug Administration (FDA).  ... management of pain severe enough to require daily, around-the-clock, ...
(Date:12/22/2014)... MONMOUTH JUNCTION, N.J. , Dec. 22, 2014 ... immunotherapy company marketing its CytoSorb® blood purification technology ... cardiac surgery patients in 28 countries worldwide, today ... Di Russo , MD, FACS, as its Senior ... 2015. Dr. Di Russo ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... 2012  Coloplast North America today announced that a federal ... Devices, Inc. (GMD) was infringing on a Coloplast Urology ... stress urinary incontinence in women. Using this approach, surgeons ... regain control of their bladder. The jury ...
... Systems (NASDAQ: DCTH ) today announced financial results ... 2012 and recent weeks.  Highlights for the ... of CE Mark approval for the second generation hemofiltration cartridge ... , Treatment of the first patient with Generation 2 ...
Cached Medicine Technology:Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc. 2Delcath Highlights First Quarter 2012 And Recent Accomplishments 2Delcath Highlights First Quarter 2012 And Recent Accomplishments 3Delcath Highlights First Quarter 2012 And Recent Accomplishments 4Delcath Highlights First Quarter 2012 And Recent Accomplishments 5Delcath Highlights First Quarter 2012 And Recent Accomplishments 6Delcath Highlights First Quarter 2012 And Recent Accomplishments 7
(Date:12/25/2014)... 2014 When head lice hits a home ... frenzy to get rid of it while keeping it from ... Gables now have the solution right in their neighborhood: ... Lice Troopers provides full spectrum head lice screening and treatment ... including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and ...
(Date:12/25/2014)... -- The risk of burns from fires and cooking ... be extra cautious, an expert says. "Between Thanksgiving ... in patients coming in with burns," said Dr. Steven ... Burn Center of Stony Brook University Hospital in New ... but if not careful, could quickly turn tragic," Sandoval ...
(Date:12/25/2014)... Thompson HealthDay Reporter WEDNESDAY, ... in on a "fountain of youth" drug that can delay ... adults, a new study suggests. Seniors received a significant ... targets a genetic signaling pathway linked to aging and immune ... The experimental medication, a version of the drug rapamycin, ...
(Date:12/25/2014)... ” was featured on NewsWatch as part of its monthly ... the iOS, Android, and Windows markets. Andrew Tropeano, a mobile ... and shared with viewers how this is an application for ... “A picture says a thousand words.” It’s true. There are ... because each picture holds a unique and special meaning. Photos ...
(Date:12/25/2014)... Each year trauma accounts for approximately 42 ... across the nation (according to the Centers for ... Hospital Ambulatory Medical Care Survey collected data from ... They estimated that there were between 3.5 and 4.4 ... diagnosis of broken bone or fracture. , When ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... 05, 2008 A new study published in Journal ... sclerosis (MS) patients to determine if the disease has affected ... progression of disability. , MS affects approximately 400,000 people in ... It is the most common cause of progressive disability in ...
... Professionals to Maintain Licensing or Certification, WASHINGTON, ... for completing an American Red Cross,First Aid/CPR Class ... happen., Red Cross has been approved as ... Association for Continuing Education and,Training (IACET). The approval ...
... survey shows people living with epilepsy often miss ... continues to build on the company,s commitment to ... XR(TM) (levetiracetam),extended-release tablets, -- Keppra XR(TM) is ... Epilepsy,Franchise, ATLANTA, Nov. 5 press release, ...
... havens for healing, but the numbers tell a different ... acquire after they,ve been admitted, and hospital-related infections continue ... heart disease. , Now, a radical new high-tech software ... these infections is now catching on faster than the ...
... for Medical Equipment, Facility,Design, Building Infrastructure and ... and NEW YORK, Nov. 5 Cirrus ... to provide a wide,range of technology and ... healthcare environments., (Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ...
... Use Tobacco Settlement Money to Keep Kids from ... Executive Director, Campaign for,Tobacco-Free Kids, WASHINGTON, Nov. ... victory for the state,s kids and health by ... reduce smoking, save lives,and lower health care costs ...
Cached Medicine News:Health News:Multiple sclerosis progression can be predicted with MRI 2Health News:American Red Cross Offering Continuing Education Credits 2Health News:Keppra XR(TM) Offers Convenient Dosing For People With Partial Onset Seizures 2Health News:Keppra XR(TM) Offers Convenient Dosing For People With Partial Onset Seizures 3Health News:Keppra XR(TM) Offers Convenient Dosing For People With Partial Onset Seizures 4Health News:Keppra XR(TM) Offers Convenient Dosing For People With Partial Onset Seizures 5Health News:Reducing epic proportions 2Health News:Cirrus Health and Siemens Announce Technology Alliance to Deliver the Physician-Driven Hospital of the Future 2Health News:Cirrus Health and Siemens Announce Technology Alliance to Deliver the Physician-Driven Hospital of the Future 3Health News:North Dakota Votes to Keep Promise to Kids by Fully Funding Tobacco Prevention 2
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: